Ligand validation:7KK3

2YQ: (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one

2YQ is a Ligand Of Interest in 7KK3 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7KK3_2YQ_A_9001	80%	62%	0.128	0.976	0.53	0.91	-	3	0	0	100%	1
7KK3_2YQ_C_9001	74%	61%	0.134	0.963	0.57	0.9	-	2	0	0	100%	1
7KK3_2YQ_B_9001	70%	63%	0.145	0.962	0.46	0.93	-	2	0	0	100%	1
7KK3_2YQ_D_9001	65%	63%	0.152	0.956	0.45	0.94	-	2	0	0	100%	1
4UND_2YQ_A_2011	19%	1%	0.184	0.779	5.64	3.17	10	15	2	0	100%	1
7KKN_2YQ_B_9002	95%	35%	0.068	0.974	0.98	1.55	-	7	0	0	100%	1
4PJT_2YQ_A_1105	88%	9%	0.095	0.971	1.92	2.46	5	11	0	0	100%	1
4PJV_2YQ_B_601	79%	9%	0.11	0.956	2.16	2.26	6	10	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.